Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

VIFOR PHARMA PORTUGAL, SA

NIF 516677586
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,329,061 39 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,329,061 39 contracts
A2 · Late Publication €7,706,009,719 530 contracts
Contract published to BASE more than 10 days after the signing date
LOW €7,706,009,719 530 contracts
A5 · Threshold Splitting €1,625,326 20 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,625,326 20 contracts
A6 · Low Competition €427,581 12 contracts
Only one bidder participated in a competitive procedure
MEDIUM €427,581 12 contracts
A9 · Abnormal Price Reduction €9,384,553,943 449 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €9,384,553,943 449 contracts
C3 · Missing Mandatory Fields €4,916,419 50 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €4,916,419 50 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

77
€718,122,634
20
€373,588,686
36
€359,681,612
33
€359,406,867
16
€350,868,764
20
€346,544,769
34
€343,424,403
13
€328,466,826
38
€322,474,759
18
€307,348,060
10
€307,102,444
21
€305,618,123
10
€303,245,798
9
€297,451,717
21
€297,014,080
16
€294,065,365
16
€292,477,138
9
€286,399,615
11
€253,828,092
8
€236,606,422
Page 1 of 3 · 53 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 12 contracts

2025001861 – Aquisição de medicamentos
PT · 11285747 · Ajuste Direto Regime G...
A6 · Low Competition
€10,795 2025-03-14
MEDICAMENTOS CAPTADORES DE IÕES - PATIRÓMERO
PT · 11024813 · Ao abrigo de acordo-qu...
A6 · Low Competition
€115,662 2024-11-14
AVACOPANO 10 MG CÁPS
PT · 11136654 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields +1
€66,225 2024-09-23
Avacopano 10 mg Cáps
PT · 10932657 · Ajuste Direto Regime G...
A6 · Low Competition
€44,150 2024-09-16
Aquisição de Patirómero 8.4 g Pó susp oral Saq AQ 2023_481 - nova qt
PT · 10893158 · Ao abrigo de acordo-qu...
A6 · Low Competition
€15,421 2024-08-26
MEDICAMENTOS CAPTADORES DE IOES - PATIROMERO - 3.º TRIMESTRE
PT · 10863807 · Ao abrigo de acordo-qu...
A6 · Low Competition
€113,734 2024-08-09
2024005259 – Aquisição de medicamentos
PT · 10834666 · Ajuste Direto Regime G...
A6 · Low Competition
€15,077 2024-07-24
Fornecimento de Patirómero ao Hospital de Santo Espírito da Ilha Terceira, EPER
PT · 10629582 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A6 · Low Competition
€28,915 2024-03-21
PATIRÓMERO 8.4 G PÓ SUSP ORAL SAQ
PT · 10831423 · Ao abrigo de acordo-qu...
A2 · Late Publication A6 · Low Competition
€7,518 2024-03-14
2024001170 – Aquisição de medicamentos
PT · 10687353 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€5,204 2024-03-12
31/380/2024 - Medicamentos Carboximaltose Férrica e Complexo Hidróxido Férrico- Polimaltose
PT · 10698106 · Ao abrigo de acordo-qu...
A2 · Late Publication A6 · Low Competition
€0 2024-01-31
61/843/2024 - Medicamentos Patiromero
PT · 10681702 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€4,879 2024-01-03
Overview
Total Value Won
€9,408,525,991
Contracts Won
811
Score 29580 · CRITICAL RISK
NIF
516677586
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.S. [P-b17a]
    Presidente
    since 2022-01-03
  • A.S. [P-b17a]
    Presidente
    since 2025-07-04
  • A.J. [P-1ffd]
    Vogal
    since 2023-08-10
  • A.J. [P-1ffd]
    Vogal
    since 2025-07-04
  • L.R. [P-b234]
    Vogal
    since 2025-07-04
  • D.A. [P-c2b1]
    Fiscal Único
    since 2024-08-12
  • D.A. [P-c2b1]
    Fiscal Único
    since 2025-07-04
  • J.C. [P-75e0]
    Fiscal Único
    since 2024-08-12
  • J.C. [P-75e0]
    Fiscal Único
    since 2025-07-04
  • A.B. [P-e78f]
    Vogal
    2022-04-11 → 2024-04-11
  • G.M. [P-e646]
    Vogal
    2022-01-03 → 2023-08-10
  • E.Y. [P-6b36]
    Fiscal Único
    2022-01-03 → 2024-08-12
  • L.M. [P-2cbf]
    Fiscal Único
    2022-01-03 → 2024-08-12
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned